WebDisclosure WebDisclosure
Basculer en Français
10713 Companies
229446 Keywords
158044 Articles
121874 Press releases
Headlines Articles Press releases Dr. Falk Pharma GmbH Remove
  1. Home
  2. Companies
  3. Dr. Falk Pharma GmbH
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 8 months ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Enhancing Portfolio in Inflammatory Diseases

    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
  • BRIEF

    published on 10/29/2024 at 13:05, 1 year 8 months ago

    Dr. Falk Pharma acquiert Kynos Therapeutics, enrichissant ainsi son portefeuille dans le domaine des maladies inflammatoires

    Maladies Inflammatoires Dr. Falk Pharma KNS366 Thérapeutique Kynos Pancréatite Aiguë
  • PRESS RELEASE

    published on 10/29/2024 at 13:00, 1 year 8 months ago

    Dr. Falk Pharma Acquires Kynos Therapeutics, Adding Acute Pancreatitis as a Therapeutic Focus and Further Strengthening Its Development Portfolio

    Dr. Falk Pharma GmbH acquires Kynos Therapeutics Ltd., focusing on inflammatory disease treatments. KNS366, a novel enzyme inhibitor, shows promise in clinical trials for acute pancreatitis
    Inflammatory Diseases Dr. Falk Pharma Kynos Therapeutics Acute Pancreatitis KNS366
    Logo of Dr. Falk Pharma GmbH
Accesswire
  • Published on 07/14/2026 at 01:45, 1 hour 52 minutes ago

    Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility

  • Published on 07/14/2026 at 00:01, 3 hours 36 minutes ago

    Captor Capital Announces Delay in its Annual Filings

  • Published on 07/13/2026 at 23:10, 4 hours 27 minutes ago

    Galaxy Ventures Inc. Announces Director Resignation

  • Published on 07/13/2026 at 21:35, 6 hours 2 minutes ago

    ATHA Energy Announces Corporate Activities Update

  • Published on 07/13/2026 at 20:00, 7 hours 37 minutes ago

    IBC Announces Share-Based Compensation to Directors

View all ACCESSWIRE
EQS Group
  • Published on 07/13/2026 at 22:30, 5 hours 7 minutes ago

    Half-year 2026 Results Media and Investor Conference Call and Webcast

  • Published on 07/13/2026 at 21:20, 6 hours 17 minutes ago

    Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

  • Published on 07/13/2026 at 21:17, 6 hours 20 minutes ago

    EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook

  • Published on 07/13/2026 at 20:48, 6 hours 49 minutes ago

    EQS-Adhoc: Gateway Real Estate AG: Forecast for the financial year 2026

  • Published on 07/13/2026 at 20:23, 7 hours 14 minutes ago

    EQS-Adhoc: TRATON SE: Preliminary operating result for Q2 2026 exceeds market expectations

View all EQS
Les Echos
  • Published on 07/13/2026 at 18:00, 9 hours 37 minutes ago

    CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense

  • Published on 07/13/2026 at 18:00, 9 hours 37 minutes ago

    PR Icade - Icade regains full ownership of the Eqho Tower in La Défense

  • Published on 07/13/2026 at 18:00, 9 hours 37 minutes ago

    THERMADOR GROUPE : 2026 half-year turnover

  • Published on 07/13/2026 at 18:00, 9 hours 37 minutes ago

    THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026

  • Published on 07/13/2026 at 17:45, 9 hours 52 minutes ago

    Weekly share buyback

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy